A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple ...

The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.

A study using wearable scanning technology has revealed how brain function differs in people with multiple sclerosis (MS). It ...

Patients suspecting they have multiple sclerosis (MS) are encountering significant delays in accessing specialist care, with some waiting up to six months for a diagnosis.

MOG-IgG positivity is rare in MS patients, complicating diagnosis and treatment, especially in Asian populations with lower ...

Jana Hlavacova, a Czech government employee who lives with MS, is helping shape policies in healthcare and the design of ...

Discover how CAR T cell therapy is breaking new ground in treating Multiple Sclerosis for the first time in the UK ...

"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Sepsis is an alarmingly common cause behind ICU admissions in patients with multiple sclerosis (MS), a retrospective, population-based cohort study indicates. Furthermore, it contributes to a ...

NATIONAL HARBOR, Maryland — Though evidence is mounting that low vitamin D levels may increase risk for the development and perhaps progression of multiple sclerosis, clinicians still do not have ...

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a ...